Mr. Speaker, my question is for the Minister of Health. A few months ago Health Canada issued an advisory that the drug known as Prepulsid would no longer be available to Canadians from pharmacies by summer's end. It also said that patients who do not respond to alternative therapies could obtain it through a special access program. Yet today patients who need this drug cannot access it, cannot obtain it. My question is why? What is Health Canada doing about this?
In the House of Commons on October 18th, 2000. See this statement in context.